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Prospective monitoring of the early treatment results  
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The current treatment of GI tract tumours is based to a large degree on the combined use of varied types of therapy: 
surgery, chemotherapy, irradiation. Severe post-operative complications may significantly affect the possibilities 
of application of non-surgical methods of treatment. Therefore, monitoring the early results of surgical treatment 
is extremely crucial to ensuring the appropriate necessary follow up and keep the risk of post-operative complica-
tions to a minimum. This paper describes the methodology of prospective collection of clinical data, which allows 
monitoring the quality of the surgical treatment of GI tumours on a current basis. On the basis of the data collected 
in the period from 2010 to 2015, the results of the analysis of three types of surgeries were presented (anterior resec-
tion of the anus, right hemicolectomy and a total gastric resection) and the actions taken on the basis of the annual 
report concerning the post-operative complication risks were described. Moreover, the examples of the application 
of prospectively collected clinical information for academic purposes were presented. 
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Introduction 
Thanks to the introduction of new programmes of mul-
tidrug chemotherapy or molecularly directed (targeted) 
variants, a significant improvement in the treatment re-
sults of the majority of GI tract tumours has been observed 
within the last 30 years. A good example here can be the 
prolongation of the overall survival period (OS) of the pa-
tients in the 4th stage of a colorectal tumour of more than 
double [1]. The treatment of a patient is on the basis of 
the combined application of many therapies (surgery, ir-
radiation, chemotherapy), and one must be aware of the 
relationship between the early results of each of the meth-
ods applied. Thus, for example, the significant toxicity of 
chemotherapy or neoadjuvant radiotherapy may affect the 
possibilities of surgical treatment. On the other hand, severe 
post-operative complications may render the continuation 
of treatment based on chemotherapy, impossible. This fact 
gains particular importance in cases where a surgery has 
a palliative character (e.g. the resection of a primary tumour 
in patients with non-resectable distant metastases which 
may be treated with chemotherapy). Given the above, it 
is necessary to monitor the quality of surgical treatment, 
measured not only with the scope of the lymphadenectomy 
performed (e.g. colorectal cancer, gastric cancer), the length 
of the resection margin (e.g. anal cancer, oesophageal can-
cer), the rate of the microscopically non-radical surgeries 
(R1 resection) or the surgeries complicated with iatrogenic 
perforation of the tumour; also the rate of post-surgical 
complications, especially those which prolong the dura-
tion of the hospital stay and/or require lengthy treatment. 
Permanent prospective supervision of the early results of 
surgical treatment, measured with a percentage of post-
operative complications, also gives the possibility of correct-
ing errors or shortcomings in the surgical technique and/or 
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in the perioperative treatment. The objective of this work is 
to present the methods of monitoring the early results of 
surgical treatment of patients with GI tract cancers treated 
at the Surgical Department of the Oncological Gastroenter-
ology Clinic (before 2013: the Clinic of the Gastrointestinal 
Tract Tumours) and to present the benefits brought by the 
systematic prospective collection of clinical data.
The methodology of data collection and 
reporting the results 
Database Chart 
Clinical data are collected in the Database Chart [To 
obtain the original contact the author]. The Chart is filled 
in by the doctor in charge of the case upon discharge from 
the ward. The chart contains five sections:
Section A — contains demographic data allowing for 
the identification of a patient, the diagnosis of the primary 
disease (which is an indication for the surgery) and the 
diagnosis of non-oncological comorbidities (which might 
potentially affect the outcome of surgical treatment), the 
data concerning synchronic or metachronic coexistence 
of other cancers (which might only have a potential effect 
on the outcome of the surgical treatment). Moreover this 
section contains data concerning the symptoms of infec-
tion diagnosed before the surgery and basic clinical data 
concerning nutritional status.
Section B — concerns the methods of pre-operative 
treatment. This section is filled only in a situation when 
a patient has received neoadjuvant therapy. Two basic 
pre-operative radiotherapy protocols have been distin-
guished: “short” irradiation, i.e. 5 × 5 Gy and “long” irradiation 
— classical radiotherapy. The above irradiation protocols 
concern patients suffering from rectal cancer. In the cases 
of a different cancer diagnosis (e.g. oesophageal cancer), the 
field of “long irradiation” should be ticked, which is the stan-
dard method of irradiating patients with a specific diagnosis. 
Moreover, this section of the chart contains information on 
pre-operative chemotherapy (provided that it was adminis-
tered), with a requirement to specify the cytostatic agents 
which were used. The final paragraph of this section specifies 
the duration time period (the number of days) between the 
end of irradiation therapy and surgery.
Section C — describes the manner of surgical treat-
ment. Apart from the date of the surgery, it contains the 
information concerning the mode of surgery, differentiat-
ing between elective and urgent modes, and the surger-
ies performed in an urgent mode (as per the definition 
contained in the regulations of the Ministry of Justice 
and Social Care) are described in the chart as emergency 
mode surgeries. It is necessary to specify the indications for 
a surgery in an urgent (emergency) mode. Apart from the 
name of the surgery performed, the surgeon specifies the 
method of reconstruction of the GI tract (provided that it 
was reconstructed) and/or the method of reconstructing 
the defect in the abdominal integuments if some artificial 
material was used (e.g. fascial mesh). The character of the 
surgery is also stated: a radical surgery in the opinion of 
the surgeon, a palliative surgery, other type of surgery (e.g. 
diagnostic laparotomy with harvesting tissue specimens). 
In cases when the macroscopic features of dissemination, 
or a non-resectable primary tumour or local recurrence is 
found perioperatively and the procedure is then limited to 
harvesting specimens, the surgery is then defined as a pal-
liative one. Also the cases of perioperative complications 
are recorded, such as: bleeding, infection of the peritoneal 
cavity, perforation of the intestine/tumour, iatrogenic spleen 
damage. Perioperative bleeding is defined as every case 
in which, as a result of blood loss into the surgical field, 
a drop in arterial pressure occurs and/or it is necessary to 
perform a perioperative blood transfusion or the blood loss 
exceeds 300 mL of blood extravasated into the surgical field 
and then suctioned. Perioperative bleeding also comprises 
cases in which it is necessary to tampon the surgical field 
as a result of the lack of possibilities of stopping the bleed-
ing with electro-coagulation, ligation, underpinning or any 
other haemostatic measure (e.g. surgicel, spongostan, tissue 
glue). A perioperative complication is defined only as such 
cases of the perforation of the intestine/tumour which oc-
curs during surgical procedures. This section also contains 
the information about the number and type of the blood 
products transfused, both before surgery and after. The 
final paragraphs of this section contain references to the 
surgeon (initials) and the duration of the surgery, from the 
moment of skin incision to the moment of placing the last 
stitch onto the integuments.
Section D — post-operative course. This section of the 
chart contains a description of all post-operative compli-
cations. The section specifies in detail 16 types of com-
plications, but it allows also for annotating some other, 
non-specified complications. Separate paragraphs refer to 
the necessities of revision surgery, post-operative mortality 
(date of death) and the duration of hospital stay calculated 
from the date of surgery (surgery date: day 0.). This section 
of the chart (similarly to all other sections) is filled in on the 
date of the patient’s discharge and its intention is to specify 
early post-operative complications. Early complications are 
defined as all adverse events which occurr within 30 days of 
the date of surgery. If no post-operative complications were 
found on the date of hospital discharge, yet complications 
occurred within one month of the surgery (e.g. discharge 
on day 7 and on day 10 — the symptoms of an anastomotic 
leak), then earlier entries in the Chart are modified/corrected 
accordingly. Moreover, if the complication results in the 
necessity of one or more revision surgeries, the number of 
such procedures is recorded. It is important though, that in 
such cases no new chart is opened (even in the case when a 
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patient requires a re-admission to hospital), but that previ-
ous entries in the existing chart are modified, including the 
duration of the hospital stay summing up the duration of 
the first stay with the consecutive one, resulting from the 
complications of the previous surgical treatment.
Section E — this is a section for additional information 
solely pertaining to the treatment of patients with rectal 
cancer.
The final paragraphs of the chart contain spaces for not-
ing remarks which could complete the data already included 
in the chart, which, in the opinion of the doctor in charge of 
the case, could be significant for the outcomes of the treat-
ment of patients with GI tract tumours (e.g. surgeries with 
the application of HIPEC — intraoperative hyperthermic 
intraperitoneal chemotherapy).
Electronic databases 
All clinical data introduced into the chart are transferred 
to electronic databases, divided into sections concerning 
various tumour locations within the gastrointestinal tract. 
There are eight types of databases:
1. Rectal cancers,
2. Colon cancer,
3. Anal cancers,
4. Gastric cancers,
5. Oesophageal cancers,
6. Pancreatic cancers,
7. Bile ducts and gallbladder cancers,
8. Other cancers of the gastrointestinal tract.
 With regards to the extensive character of the surgical 
procedures performed at the Surgical Ward of the On-
cological Gastroenterology Clinic as well extending the 
scope of activity to new therapeutic procedures, four 
additional electronic databases have been created:
9. Other oncological diseases (not connected with the 
GI tract),
10. Non-oncological diseases surgically treated,
11. Reconstructive surgeries,
12. Liver surgeries.
All the electronic databases are recorded in an Excel 
Program with the possibility of being transferred to other 
programs allowing for a detailed statistical analysis (e.g. 
SPSS programme). Only a limited number of staff have ac-
cess to electronic databases (the Head of the Surgical Ward 
[TO], and the Co-coordinator of the Surgical Ward [AR]). The 
databases are password-protected.
Verification of the quality of the collected data 
There are two levels of control for the collected data.
Level one — this is a verification of the data contained 
in the chart, which is performed upon the patient’s dis-
charge from hospital. The persons responsible for this level 
of verification is the Head of the Surgical Ward, who, upon 
signing the discharge summary, verifies the accuracy of 
the data collected. The source material then is the patient’s 
information chart and the discharge summary. 
Level two — entering data into the electronic database. 
The person responsible for the accuracy of entering this 
data into the databases is the Co-coordinator of the Surgi-
cal Ward, who is, at the same time, the administrator of the 
electronic databases. The source material is, in that case, 
the chart and the patient’s information file as recorded in 
the ClinNet system.
Reporting results 
The coordinator of the surgical team is responsible for 
the prospective monitoring of the early results of the surgical 
treatment. This is made possible thanks to analysis of the data 
contained in the electronic database. In the case of finding 
an increase in the rate of post-operative complications in 
a specific group of patients, the Coordinator informs the Head 
of the Surgical Ward and then the problem is discussed by 
the entire surgical team. Moreover, the Coordinator of the 
Surgical team prepares periodic reports (every 6 to 12 months 
concerning all electronic databases. These reports, in the form 
of a presentation, are presented to the whole surgical team. 
They concern both the current period and comparisons with 
the previous periods of the Clinic’s activity.
Benefits from a prospective evaluation  
of the quality of surgical treatment 
The discussion of all the benefits from the above de-
scribed methods of prospective collection of clinical data 
would exceed the limits of this publication. However, two 
basic aspects must be distinguished here:
 — clinical (current) which allows for monitoring early re-
sults of treatment and implementing at an appropriate 
moment (i.e. as soon as possible) the widely understood 
methods preventing the occurrence of post-operative 
complications; 
 — scientific (long-term) allowing for constructive research 
projects on the basis of the collected clinical material. To 
this end, the results of pathomorphology reports and 
long term follow-up results are attached to the collected 
clinical information.
Examples of clinical application 
Prospective accumulation of clinical data allows for 
monitoring the percentage of the performed surgeries of 
a specific type and the related risk of post-operative compli-
cations on a current basis. The analysis of the three selected 
types of surgeries are discussed below.
Anterior resection in patients with rectal adenocarcinoma
Between July 2010 and December 2015, surgical treat-
ment was performed in 405 patients of primary rectal cancer. 
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Tumour resection was performed in 375 patients (93%). In this 
group, the median distance between the edge of the anus and 
the inferior border of the tumour was 5 cm. The total rate of 
resections saving the sphincters was 72.5%, whereas the rate 
of surgeries with immediate reconstruction of the continuity 
of the alimentary tract — 60%; (anterior resection: n = 219, 
proctocolectomy with ileoanal anastomosis: n = 3, local resec-
tion: n = 3). The rate of symptomatic anastomotic leakages 
after the anterior resection varied between 5% and 13%. At 
the same time, the rate of anastomoses protected with stomy 
was analysed (protective loop ileostomy) (Fig.1). Analysis of 
the database performed at the end of 2014 showed a slight 
decrease in the rate of sphincter-saving surgeries, i.e. mainly 
performed during anterior resections. Special attention was 
paid to the increase in symptomatic anastomotic leaks (to 
12.8% in comparison with 5.2% in 2013). This was connected 
with a decrease in the number of surgeries in which the 
anastomosis was protected with a stomy: 19.1% in 2014 in 
comparison with 36.2% in 2013. As a result of this analysis, 
in 2015, a protective loop ileostomy was performed in 30% 
of cases, and, consequently, the rate of anastomotic leaks 
was decreased. Some worrying data arrived in 2015, mainly 
with respect to significant decreases in sphincter saving 
surgeries and the proportion of anterior resections per-
formed (59% in comparison with 75% in 2014 and 45.5% 
in comparison with 61.8% in 2014, respectively). The data 
collected between January and June 2016 are indicative 
of the decrease in this worrying tendency, as during that 
period the rate of sphincter sparing surgeries was 74.3%, 
whilst anterior resections — 62.9%. The rate of anastomosis 
leaks is monitored on an ongoing basis.
Right hemicolectomy in patients with adenocarcinoma  
of the right-side of the colon 
The analysis performed after the completion of the data 
concerning 2014 pointed to a growing tendency in the rate 
Figure 1. Anterior resection in primary rectal adenocarcinoma
Figure 2. Right hemicolectomy in the tumour of the right-side of the colon 
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those closing the duodenum) was observed. This worry-
ing tendency was successfully halted in 2015. Analysis of 
complications after a total gastrectomy points to a stable, 
good situation in the early results of the surgical treatment 
of patients with gastric cancer. The rate of the complications, 
including the anastomotic leaks, remains at an acceptable 
level. What draws particular attention is the fact that the rate 
of revision surgeries is 9.7%, whilst post-operative mortality 
remains below 1.5%. 
Examples of scientific application 
Collected prospective clinical data were used for an 
analysis, the objective of which was the verification of the 
usefulness in clinical practice of the “risk scale of anastomotic 
leak after anterior resection”, worked out on the basis of 
retrospective evaluation of 501 patients operated at the 
Oncology Centre between 1996–2003 (Tab. I). The results 
of the analysis performed on the basis of the EBD “Colon 
Cancers” are presented in Table II. Depending on the score, 
three groups of patients were distinguished, where the 
rate of symptomatic anastomotic leak varied between 4.7% 
and 15.8%. Protective colostomy seems to be necessary in 
patients with a high risk of anastomotic leak; in these cases 
the score of the points corresponding to some specific risk 
factors is from 5 to 8. The analysis of these results carried out 
by a surgical team of the Clinic contributed to a decrease 
in the rate of anastomotic leaks in 2015, and, moreover, 
allowed the design of a multicentre prospective research 
project conducted under the auspices of the Polish Society 
of Surgical Oncology (research project: PSSO_01). Moreover, 
on the basis of EBD “Colon Cancers”, there are prospective 
studies whose aim is to determine the factors which influ-
ence the quality of mesorectal excision, specifying the prog-
Figure 3. Total gastrectomy in gastric tumour
of revision surgeries after right hemicolectomies (Fig. 2). 
A fact that raised particular concern was the high rate of 
anastomotic leaks (8%). In the discussion of the surgeons’ 
team, publications concerning the risk of complications 
were analysed with special attention paid to the techni-
cal aspects of making anastomoses after the resection of 
the right side of the colon (the type of staplers used, the 
height of the staples, additional sutures subsiding the sta-
ple lines etc.). Although clinical data for 2015 are indicative 
of a decrease in the rate of revision surgeries, the rate of 
anastomotic leaks remained at a comparatively high level 
(9%). What is more, in 2015, 3 cases of deaths were observed 
in the post-operative period after a right hemicolectomy; 
this happened for the first time within a 6-year observation 
period. A detailed analysis of these cases showed that the 
direct cause of death was multi-organ dysfunction. All these 
patients were re-operated on The indications for a revision 
surgery were: anastomotic leak (n = 1), wound dehiscence 
(n = 1) and post-operative bleeding (n = 1). The age of the 
patients was 77, 79 and 81 years respectively. All of them 
had a history of comorbidities: heart ischemic disease (n = 3), 
arterial hypertension (n = 3), diabetes (n = 2), COPD (n = 1). 
The conclusions which may be drawn from the analysis of 
these three cases comprise the necessity of a detailed as-
sessment of the risk of severe post-operative complications 
in patients qualifying for such surgeries.
Total gastric resection in patients with  
a primary gastric tumour 
In the period between 2010 and 2013, a continual de-
crease in the rate of complications after a total gastrectomy 
was observed (Fig. 3). In 2014, an increase in the number 
of complications related to the anastomotic leak (mainly 
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nostic significance of the number of resected lymph nodes 
after irradiation and colon cancer resection or the factors 
allowing for an immediate reconstruction of the continu-
ity of the alimentary tract after the resection of the colon 
cancer. Associating the data concerning the post-operative 
complications contained in EBD “Gastric Cancers” with the 
evaluation of the nutritional status of the patients in the 
NRS 2002 scale, allowed for an evaluation of the usefulness 
of this scale for the prognoses of the risk of post-operative 
complications. The results of this analysis were presented 
during the XVIII Congress of the Polish Society of Parenteral 
and Enteral Nutrition (POLSPEN) in 2016. 
Final remarks
Analysis of single cases of the failures of surgical treat-
ment, although extremely valuable, does not usually allow 
for drawing conclusions which might be applicable for 
a general population of patients. In analysing a single case, 
the score is either 0 or 1 (either there was an anastomotic 
leak — 1, or not — 0). The analysis of a larger group of 
patients, as was shown with the example of the clinical ap-
plication, allows for drawing more general conclusions. The 
most significant advantage of the prospective monitoring 
of the quality of treatment is the possibility of immediate 
reaction to a situation that might occur. The identifica-
tion of the existing problem and its description, offers 
the chance to find a solution, not only in the available 
publications concerning the research in other centres, but 
also within a specific surgical team. A prospective collec-
tion of the clinical material also allows for minimising the 
risk of omitting any information that might be significant 
from a clinical point of view. In our experience, the ap-
propriate processing of the data collected in the annual 
summaries of the team’s work whose intention should not 
definitely be the internal competition, raises awareness 
of the existing complications as well as the necessity for 
continual improvement of professional qualifications. It 
is a generally known fact that in patients operated on for 
oesophageal, pancreatic, gastric or colorectal cancers, the 
experience of the surgeon remains one of the most signifi-
cant prognostic factors. A population study carried out in 
Great Britain showed that mortality rate after a resection of 
oesophageal, gastric and pancreatic cancers was indirectly 
proportional to the number of cases previously operated 
Table I. The risk scale of the anastomotic leak after anterior resection — retrospective analysis of 501 cases of the patients operated on between 1996–2003
Category Description Score 
Gender Female 0
Male 1
Pre-operative radiotherapy No 0
Yes 1
The anastomotic level from the edge of the rectum (cm) > 5 0
> 3–5 2
≤ 3 3
Perioperative bleeding (blood loss > 200mL) No 0
Yes 1
Surgery duration (min.) ≤ 150 0
> 150–180 1
> 180 2
Table II. Anastomotic leak after anterior resection illustrated with the scoring scale in the prospective clinical material between 2010–2014
Anastomotic leak risk category The number and rate  
of leaks (in total)
Rate of anastomotic leaks 
Without protective stomy With protective stomy
Low risk 
Score: 0–2
n = 86
4 (4.7%) 5.2% 0%
Medium risk 
Score: 3–4
n = 72
6 (8.3%) 10.4% 4.2%
High risk 
Score: 5–8
n = 38
6 (15.8%) 38.5% 4.0%
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on by the surgeon [2]. Similar observations concern the risk 
of post-operative complications in patients operated on for 
colorectal cancer [3], yet it is the individual experience of 
the surgeon and the entire surgical team is built not only 
from the number of the surgeries performed, but it comes 
also from a critical analysis of the results and the rate of 
the complications, perioperative mortality, the length of 
hospital stay etc. Therefore, it is not a surprise that an in-
creasing number of data supports the argument that every 
surgeon should have the chance to critically monitor the 
results of the treatment they have conducted [4]. However, 
monitoring the early results of surgical treatment fits into 
a much wider context, i.e. a comprehensive evaluation 
of the quality of the oncological treatment. With this in-
tention, in many European countries, some special pro-
grammes and registers were created, allowing for an ongo-
ing assessment of the situation concerning the treatment 
of patients with specific cancers. An example to follow 
might be the Dutch Surgical Colorectal Audit (DSCA) [5]. 
Within the first two years of launching this programme, all 
Dutch hospitals were covered by it. The rate of compliance 
of reported cases in comparison with the Netherlands Can-
cer Registry [NCR] in 2010–2012 was 92–95% respectively. 
This programme recorded data concerning the advance-
ment stage of the disease, the methods of treatment and 
its results. Within three years of the audit, some improve-
ment in the compliance of the diagnostic process and the 
treatment with the binding standards was observed and, 
at the same time, a significant decrease in the rate of post-
operative complications, revision surgeries and mortality 
was recorded. Similar programmes have also been created 
in other countries [6]. Another example here might be the 
American National Cancer DataBase (NCDB), which collects 
information concerning, among others, demographical 
data (age, gender, race, region of residence), tumour char-
acteristics (location, histological type, size, differentiation 
grade, advancement stage), method of treatment (type 
of surgery, chemotherapy and radiotherapy programme) 
and overall survival. Thanks to this information, it was ob-
served that post-operative mortality after the resection 
of oesophageal cancer, measured within the period of 
90 days post-operatively, is double as the mortality observed 
within the first 30 days post-operatively [7]. The authors of 
this article are aware that the introduction of a register in 
Poland, such as NCDB, or carrying out an audit like DSCA, 
would require the introduction of legislative changes, and 
first and foremost, would incur significant costs which 
our system cannot currently afford. That is why it would 
be even more valuable to introduce a uniform method 
of prospective data collection concerning the results of 
surgical treatment in other oncological centres. Even if this 
data is not concerned with all organ locations, it would still 
be worthwhile to unify the data concerning at least one 
cancer (e.g. gastric, cancer or colon cancer). It is not about 
competition between individual centres, but about a reli-
able and critical outlook on the actual situation concerning 
both early and late results of GI tract cancers. Once the 
clinical data, collected in a unified manner (as is the case 
in the presented example of EBD), are completed with the 
results contained in pathomorphological protocols and 
with remote observations on the basis of the follow-up 
carried out in every centre or on the basis of the National 
Cancer Register, both prospective and retrospective studies 
could be constructed, based on this significantly valuable 
material. Progress in combined treatment raises our hopes 
for an improvement in the oncological results, which, how-
ever, does not release a surgeon from the obligation of 
due diligence in their care of carrying out the best quality 
of surgery possible. After all, possible complications lead 
not only to an increase in treatment costs, but also, for 
some patients, complications mean losing the chance for 
receiving a combined treatment and, eventually, overcom-
ing their cancer.
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